Lingli Zhang

Papers

Total Citations

H-Index

About

Lingli Zhang is a leading researcher in pharmaceutical care and intravenous admixture services, with a particular focus on the integration of automation and robotics in hospital pharmacy settings. Her most-cited work, a 2023 systematic review on intravenous compounding robots, synthesizes evidence to guide decision-makers in adopting these technologies for safer, more efficient medication preparation. This study, cited 12 times, addresses a critical gap in best practices for pharmacy intravenous admixture services, highlighting her role in bridging clinical pharmacy with health technology assessment. Zhang’s contributions are pivotal in advancing patient safety and operational precision, as her research provides actionable insights for hospitals evaluating robotic systems. By systematically evaluating the benefits and limitations of compounding robots, she has helped shape standards in sterile compounding, reducing human error and contamination risks. Her work is widely referenced by pharmacy practitioners and policymakers, underscoring its impact on modernizing hospital pharmacies. Zhang’s dedication to evidence-based innovation positions her as a key voice in the evolution of pharmacy practice, making her research essential reading for students and professionals interested in the intersection of automation, patient safety, and clinical pharmacy.